SEC 13F Intelligence

Welch & Forbes LLC / LLY

Welch & Forbes LLC’s Eli Lilly & Co Position

Does Welch & Forbes LLC own Eli Lilly & Co (LLY)? Yes — 168.2K shares worth $155M (+2.00% of its 13F portfolio) as of Q1 2026, up from 167.8K shares the prior filed quarter.

Position Value
$155M
Q1 2026
Shares
168.2K
% of Portfolio
+2.00%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $16MQ4 ’18Q1 ’19: $17MQ2 ’19: $15MQ3 ’19: $15MQ4 ’19: $17MQ4 ’19Q1 ’20: $18MQ2 ’20: $21MQ3 ’20: $19MQ4 ’20: $22MQ4 ’20Q1 ’21: $24MQ2 ’21: $30MQ3 ’21: $30MQ4 ’21: $36MQ4 ’21Q1 ’22: $37MQ2 ’22: $40MQ3 ’22: $39MQ4 ’22: $44MQ4 ’22Q1 ’23: $42MQ2 ’23: $57MQ3 ’23: $70MQ4 ’23: $78MQ4 ’23Q1 ’24: $106MQ2 ’24: $128MQ3 ’24: $120MQ4 ’24: $113MQ4 ’24Q1 ’25: $123MQ2 ’25: $116MQ3 ’25: $128MQ4 ’25: $180MQ4 ’25Q1 ’26: $155Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026168.2K$155M+2.00%
Q4 2025167.8K$180M+2.18%
Q3 2025168.2K$128M+1.55%
Q2 2025149.4K$116M+1.45%
Q1 2025148.5K$123M+1.61%
Q4 2024147.0K$113M+1.46%
Q3 2024134.9K$120M+1.52%
Q2 2024137.4K$128M+1.71%
Q1 2024135.8K$106M+1.45%
Q4 2023133.1K$78M+1.17%
Q3 2023129.8K$70M+1.15%
Q2 2023121.9K$57M+0.90%
Q1 2023122.8K$42M+0.71%
Q4 2022121.2K$44M+0.79%
Q3 2022121.6K$39M+0.77%
Q2 2022124.2K$40M+0.74%
Q1 2022128.4K$37M+0.58%
Q4 2021129.5K$36M+0.54%
Q3 2021129.3K$30M+0.50%
Q2 2021129.2K$30M+0.50%
Q1 2021127.7K$24M+0.44%
Q4 2020128.5K$22M+0.42%
Q3 2020128.4K$19M+0.41%
Q2 2020125.5K$21M+0.48%
Q1 2020128.5K$18M+0.50%
Q4 2019130.1K$17M+0.38%
Q3 2019130.8K$15M+0.35%
Q2 2019133.5K$15M+0.36%
Q1 2019134.5K$17M+0.44%
Q4 2018134.5K$16M+0.44%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Welch & Forbes LLC’s full portfolio or all institutional holders of LLY.